LEADER 01641nam 2200385Ia 450 001 996396645103316 005 20200824132616.0 035 $a(CKB)4940000000056961 035 $a(EEBO)2264197708 035 $a(OCoLC)ocm12266159e 035 $a(OCoLC)12266159 035 $a(EXLCZ)994940000000056961 100 $a19850715d1667 uy | 101 0 $aeng 135 $aurbn||||a|bb| 200 14$aThe clerk's tutor for writing$b[electronic resource] /$fWritten and engraved by Edw. Cocker 210 $aLondon $cPrinted for Jo. Streater, Ja. Flesher, and Hen. Twyford. Sold in Vine Court Middle Temple$d1667 215 $a[12], 360 p., [6] leaves of plates 300 $aEngraved t.p. containing a perpetual almanac; six leaves of writing specimens. 300 $a"This book is by Hawkins ... and the t.p. only claims the plates, not the letterpress for Cocker"--DNB (concerning The young clerk's tutor for writing, 1st ed., 1660?). 300 $aReproduction of original in Newberry Library. 300 $aImperfect: lacks p. 185-208. 300 $aThis item is identified at reel 22:9 as Wing C4832A (number cancelled in Wing CD-ROM, 1996), and at reel 2265:8 as Wing (CD-ROM, 1996) H1174A. 330 $aeebo-0101 606 $aCopybooks$zEngland$vEarly works to 1800 606 $aForms (Law)$zEngland$vEarly works to 1800 615 0$aCopybooks 615 0$aForms (Law) 700 $aHawkins$b John$f17th cent.$01002666 701 $aCocker$b Edward$f1631-1675.$01001101 801 0$bEAE 906 $aBOOK 912 $a996396645103316 996 $aThe clerk's tutor for writing$92339005 997 $aUNISA LEADER 02919nam 2200841z- 450 001 9910557114503321 005 20210501 035 $a(CKB)5400000000040901 035 $a(oapen)https://directory.doabooks.org/handle/20.500.12854/69079 035 $a(oapen)doab69079 035 $a(EXLCZ)995400000000040901 100 $a20202105d2020 |y 0 101 0 $aeng 135 $aurmn|---annan 181 $ctxt$2rdacontent 182 $cc$2rdamedia 183 $acr$2rdacarrier 200 00$aOutcomes and Therapeutic Management of Bladder Cancer 210 $aBasel, Switzerland$cMDPI - Multidisciplinary Digital Publishing Institute$d2020 215 $a1 online resource (120 p.) 311 08$a3-03936-934-2 311 08$a3-03936-935-0 330 $aBladder cancer is the second most common genitourinary malignancy, with 81,190 estimated new diagnoses in 2018, in the United States alone. Transurethral resection of the bladder and radical cystectomy with bilateral pelvic lymph node dissection constitute the standard treatment for non-muscle invasive or very high-risk non-muscle invasive bladder cancer, respectively. However, survival expectations have not shown to improve in the last 20 years, and new diagnostic and therapeutic tools are urgently needed to improve the outcomes of this potentially lethal disease. 606 $aMedicine$2bicssc 610 $aadjuvant 610 $aage 610 $aanesthesia recovery periods 610 $abiomarkers 610 $abladder cancer 610 $achemotherapy 610 $aclear-cell adenocarcinoma 610 $acognitive impairment 610 $afemale 610 $aFOXA1 610 $agamma-cyclodextrins 610 $aGATA3 610 $aglycogen 610 $ahuman epidermal growth factor receptor 2 610 $aimmunotherapy 610 $aindoleamine 2,3-dioxygenase 610 $aintracorporeal neobladder 610 $aKRT20 610 $amethylation 610 $amolecular markers 610 $amRNA 610 $amuscle-invasive bladder cancer 610 $an/a 610 $aneoadjuvant 610 $aneuromuscular blockade 610 $anodal disease 610 $aopen 610 $aoutcome 610 $aoutcomes 610 $aPCR 610 $apN1 610 $aprogrammed death ligand-1 610 $apropensity score 610 $aradical cystectomy 610 $arobotic 610 $arobotic radical cystectomy 610 $arobotic-assisted 610 $aSEER program database 610 $asex-sparing 610 $asurvival 610 $aurinary bladder 610 $aurothelial carcinoma 615 7$aMedicine 700 $aMoschini$b Marco$4edt$0481847 702 $aMoschini$b Marco$4oth 906 $aBOOK 912 $a9910557114503321 996 $aOutcomes and Therapeutic Management of Bladder Cancer$93038144 997 $aUNINA